Pharmaceuticals Related News
UK’s first investment fund dedicated to psychedelic healthcare
In a first for the UK, an investment fund dedicated to psychedelic healthcare has been launched.
The new fund comes as recent rigorous clinical trials...
Meningococcus B vaccine shows 79% effectiveness
A vaccine for the deadly Meningococcus B has been shown to have 79% effectiveness in patients under the age of 18.
Meningococcus group B is...
COVID-19 vaccine added to damages scheme in case of severe disability
The UK has taken the precautionary measure of adding COVID-19 to its Vaccine Damage Payments Scheme so people will be able to access financial...
Pfizer-BioNTech COVID-19 vaccine authorised by UK Government
The UK Government has authorised the Pfizer-BioNTech COVID-19 vaccine which will be made available from next week.
The UK Government has granted a temporary authorisation...
Establishing a Pharmaceutical Strategy for Europe
The European Commission has adopted a Pharmaceutical Strategy for Europe which aims to ensure access to medicines and support innovation and sustainability in the...
European Commission approves contract for potential COVID-19 vaccine
The European Commission has approved a contract with Moderna to secure access to a potential COVID-19 vaccine.
The contract will be the sixth one made...
Clinical trial explores psychedelic treatments for PTSD in veterans
A company exploring the efficacy of psychedelic treatments for PTSD in veterans has announced the international expansion of its Phase 2A clinical trials.
The Mydecine...
Nasal spray clinical trial to investigate prevention of COVID-19 infection
A randomised, double blind trial will be testing the efficacy of a nasal spray to protect frontline healthcare workers against COVID-19.
The spray is the...
Sex differences and women’s representation in clinical trials
Professors Irving Zucker and Brian J Prendergast tell us about the impacts on women of sex biases in clinical drug trials.
In 1993, the US...
Patients donate to WHO COVID-19 Solidarity Response Fund
A total of 9,635 patients have come together to help defeat the coronavirus by donating £16,915 for the World Health Organisation’s (WHO) COVID-19 Solidarity...
Researchers find better way to repair damaged nerve insulation
In a mouse study, researchers have found a better way than natural healing to repair damaged insulation surrounding nerve cells.
Normally, the natural healing process...
New study shows escalation in UK opioid use over the last decade
A new study of two million opioid users has shown that prescriptions for the addictive drug codeine jumped by a factor of five between...
UK government responds to ACMD report on the misuse of fentanyl
The UK government has responded to the Advisory Council on the Misuse of Drugs (ACMD) report on the misuse of fentanyl to confirm it...
UK medicines regulator joins ACSS consortium of regulators
The UK medicines regulator, Medicines and Healthcare products Regulatory Agency (MHRA) has now joined the Australia-Canada-Singapore-Switzerland (ACSS) Consortium.
The ACSS Consortium will now be known...
Cutting-edge treatments to be fast-tracked to UK patients
NHS patients could have quicker access to cutting-edge medical treatments as the UK teams up with international collaborators to fast-track the approval process.
Following the...
European Commission purchases 500,000 courses of Remdesivir
The European Commission has signed a joint procurement framework contract with the pharmaceutical company Gilead for the supply of up to 500,000 treatment courses...
MEPs call for Pharmaceutical Strategy to tackle antimicrobial resistance
MEPs have called on the European Commission to tackle antimicrobial resistance (AMR) through the new Pharmaceutical Strategy for Europe.
The European Commission’s Pharmaceutical Strategy for...
Farxiga granted Breakthrough Therapy Designation by FDA
Farxiga has been given Breakthrough Therapy Designation by the Food and Drug Administration (FDA) for patients with chronic kidney disease.
Farxiga has recently shown encouraging...
Could COVID-19 provide a new target for non-opioid pain relief?
COVID-19 could provide a new target for non-opioid pain relief according to new research, which has found that the virus can relieve pain.
The findings...
Combatting resistant depression with DMT and digital therapy
A wellbeing company is developing novel formulations of dimethyltryptamine (DMT) to help combat treatment resistant depression in combination with digital psychotherapy.
Nearly 264 million people live...
